Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

AVEO Pharmaceuticals Price to Sales Ratio 2009-2020 | AVEO

Historical PS ratio values for AVEO Pharmaceuticals (AVEO) over the last 10 years. The current P/S ratio for AVEO Pharmaceuticals as of May 28, 2020 is .
  
AVEO Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2020-05-28 9.21 5.29
2020-03-31 3.62 $1.74 2.08
2019-12-31 0.62 $1.81 0.34
2019-09-30 0.84 $1.88 0.45
2019-06-30 0.67 $0.48 1.39
2019-03-31 0.82 $0.47 1.73
2018-12-31 1.60 $0.44 3.65
2018-09-30 3.31 $0.33 9.94
2018-06-30 2.26 $0.52 4.36
2018-03-31 2.90 $0.52 5.61
2017-12-31 2.79 $0.76 3.66
2017-09-30 3.65 $0.77 4.72
2017-06-30 2.22 $0.51 4.33
2017-03-31 0.59 $0.51 1.16
2016-12-31 0.54 $0.38 1.40
2016-09-30 0.89 $1.01 0.88
2016-06-30 0.96 $3.54 0.27
2016-03-31 0.92 $3.54 0.26
2015-12-31 1.26 $3.35 0.38
2015-09-30 1.21 $2.73 0.44
2015-06-30 1.74 $0.24 7.24
2015-03-31 1.45 $0.57 2.53
2014-12-31 0.84 $3.51 0.24
2014-09-30 1.11 $3.55 0.31
2014-06-30 1.83 $3.44 0.53
2014-03-31 1.50 $3.15 0.47
2013-12-31 1.83 $0.25 7.18
2013-09-30 2.06 $3.77 0.55
2013-06-30 2.50 $3.94 0.63
2013-03-31 7.35 $4.31 1.70
2012-12-31 8.05 $4.45 1.81
2012-09-30 10.41 $1.13 9.21
2012-06-30 12.16 $1.73 7.03
2012-03-31 12.41 $8.50 1.46
2011-12-31 17.20 $43.95 0.39
2011-09-30 15.39 $48.36 0.32
2011-06-30 20.61 $49.54 0.42
2011-03-31 13.32 $47.40 0.28
2010-12-31 14.62 $28.92 0.51
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.148B $0.029B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.844B 14.52
Gilead Sciences (GILD) United States $94.479B 12.25
CSL (CSLLY) Australia $86.864B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.918B 49.44
Regeneron Pharmaceuticals (REGN) United States $63.614B 24.52
Illumina (ILMN) United States $54.832B 56.35
Biogen (BIIB) United States $49.038B 8.39
Seattle Genetics (SGEN) United States $26.234B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.267B 10.86
Incyte (INCY) United States $21.857B 0.00
Moderna (MRNA) United States $20.618B 0.00
Genmab (GMAB) Denmark $20.217B 16.65
Genmab (GNMSF) Denmark $19.174B 56.92
BioMarin Pharmaceutical (BMRN) United States $19.096B 173.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.282B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.059B 38.67
Exact Sciences (EXAS) United States $12.562B 0.00
BeiGene (BGNE) Cayman Islands $12.557B 0.00
Sarepta Therapeutics (SRPT) United States $11.932B 0.00
BioNTech SE (BNTX) Germany $10.605B 0.00
QIAGEN (QGEN) Netherlands $9.894B 28.77
Bio-Techne Corp (TECH) United States $9.877B 65.25
Horizon Therapeutics Public (HZNP) Ireland $9.300B 22.89
ARGENX SE-ADR (ARGX) Netherlands $9.058B 0.00
Guardant Health (GH) United States $8.309B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.901B 0.00
Immunomedics (IMMU) United States $7.689B 0.00
Exelixis (EXEL) United States $7.461B 26.16
Ascendis Pharma (ASND) Denmark $7.044B 0.00
Repligen (RGEN) United States $6.758B 118.54
Acceleron Pharma (XLRN) United States $5.330B 0.00
Adaptive Biotechnologies (ADPT) United States $4.938B 0.00
Reata Pharmaceuticals (RETA) United States $4.894B 0.00
MyoKardia (MYOK) United States $4.675B 0.00
Mirati Therapeutics (MRTX) United States $4.495B 0.00
China Biologic Products (CBPO) China $4.335B 24.10
Emergent Biosolutions (EBS) United States $4.298B 28.17
MorphoSys AG (MOR) Germany $4.234B 32.84
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.092B 0.00
Zai Lab (ZLAB) China $3.972B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.802B 83.08
Momenta Pharmaceuticals (MNTA) United States $3.733B 0.00
Vir Biotechnology (VIR) United States $3.721B 0.00
Blueprint Medicines (BPMC) United States $3.630B 0.00
Bluebird Bio (BLUE) United States $3.384B 0.00
Halozyme Therapeutics (HALO) United States $3.186B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.184B 0.00
Amicus Therapeutics (FOLD) United States $3.141B 0.00
NeoGenomics (NEO) United States $2.914B 212.77
Denali Therapeutics (DNLI) United States $2.896B 0.00
Arena Pharmaceuticals (ARNA) United States $2.806B 0.00
UniQure (QURE) Netherlands $2.793B 0.00
Alkermes (ALKS) Ireland $2.646B 52.09
Amarin (AMRN) Ireland $2.633B 0.00
Novavax (NVAX) United States $2.599B 0.00
Insmed (INSM) United States $2.521B 0.00
Fate Therapeutics (FATE) United States $2.503B 0.00
Alector (ALEC) United States $2.487B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.396B 0.00
Viela Bio (VIE) United States $2.327B 0.00
Principia Biopharma (PRNB) United States $2.126B 0.00
Inovio Pharmaceuticals (INO) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Epizyme (EPZM) United States $1.861B 0.00
Arvinas (ARVN) United States $1.756B 0.00
Zymeworks (ZYME) Canada $1.702B 0.00
Adverum Biotechnologies (ADVM) United States $1.625B 0.00
Ligand Pharmaceuticals (LGND) United States $1.618B 62.99
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.546B 0.00
Akcea Therapeutics (AKCA) United States $1.526B 0.00
Editas Medicine (EDIT) United States $1.501B 0.00
REGENXBIO (RGNX) United States $1.484B 0.00
Mesoblast (MESO) Australia $1.469B 0.00
Twist Bioscience (TWST) United States $1.468B 0.00
PHARMA MAR SA (PHMMF) Spain $1.405B 0.00
Intra-Cellular Therapies (ITCI) United States $1.397B 0.00
NGM Biopharmaceuticals (NGM) United States $1.390B 0.00
I-Mab (IMAB) China $1.389B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Coherus BioSciences (CHRS) United States $1.294B 9.03
Beam Therapeutics (BEAM) United States $1.288B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.216B 0.00
Mersana Therapeutics (MRSN) United States $1.161B 0.00
Myriad Genetics (MYGN) United States $1.074B 55.42
Sorrento Therapeutics (SRNE) United States $1.038B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Pharming Group (PHGUF) Netherlands $0.933B 0.00
NextCure (NXTC) United States $0.914B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Compugen (CGEN) Israel $0.847B 0.00
Heska (HSKA) United States $0.813B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.806B 0.00
Cue Biopharma (CUE) United States $0.774B 0.00
Cellectis S.A (CLLS) France $0.769B 0.00
Cara Therapeutics (CARA) United States $0.760B 0.00
Codexis (CDXS) United States $0.744B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.732B 0.00
Alcobra (ARCT) United States $0.731B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Retrophin (RTRX) United States $0.692B 0.00
Kala Pharmaceuticals (KALA) United States $0.669B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.658B 0.00
Castle Biosciences (CSTL) United States $0.657B 0.00
NantKwest (NK) United States $0.651B 0.00
Morphic Holding (MORF) United States $0.645B 0.00
Vericel (VCEL) United States $0.642B 118.58
Adaptimmune Therapeutics (ADAP) United Kingdom $0.632B 0.00
Stemline Therapeutics (STML) United States $0.623B 0.00
Bellus Health (BLU) Canada $0.622B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.603B 5.16
Syndax Pharmaceuticals (SNDX) United States $0.579B 0.00
MeiraGTx Holdings (MGTX) United States $0.562B 0.00
Frequency Therapeutics (FREQ) United States $0.561B 0.00
Athersys (ATHX) United States $0.546B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.542B 0.00
DBV Technologies S.A (DBVT) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
AnaptysBio (ANAB) United States $0.525B 0.00
AC Immune SA (ACIU) Switzerland $0.516B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.485B 15.61
Agenus (AGEN) United States $0.482B 0.00
BioDelivery Sciences (BDSI) United States $0.479B 25.21
Aquinox Pharmaceuticals (NLTX) United States $0.464B 0.00
VBI Vaccines (VBIV) United States $0.457B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.455B 0.00
Cel-Sci (CVM) United States $0.455B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Dynavax Technologies (DVAX) United States $0.446B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.444B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Syros Pharmaceuticals (SYRS) United States $0.435B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Merus (MRUS) Netherlands $0.411B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Seres Therapeutics (MCRB) United States $0.402B 0.00
MiMedx (MDXG) United States $0.401B 0.00
CytomX Therapeutics (CTMX) United States $0.401B 0.00
Intrexon (PGEN) United States $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.385B 7.62
PDL BioPharma (PDLI) United States $0.382B 328.00
Precision BioSciences (DTIL) United States $0.366B 0.00
WAVE Life Sciences (WVE) Singapore $0.358B 0.00
Menlo Therapeutics (MNLO) United States $0.342B 0.00
Kamada (KMDA) Israel $0.341B 14.20
Geron (GERN) United States $0.323B 0.00
Selecta Biosciences (SELB) United States $0.322B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.321B 0.00
Avid Bioservices (CDMO) United States $0.319B 0.00
MannKind (MNKD) United States $0.318B 0.00
OSMOTICA PHARM (OSMT) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Verastem (VSTM) United States $0.286B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.274B 0.00
Abeona Therapeutics (ABEO) United States $0.271B 0.00
Liquidia Technologies (LQDA) United States $0.269B 0.00
Cellular Biomedicine (CBMG) United States $0.268B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Gritstone Oncology (GRTS) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.244B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.242B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.239B 0.00
Affimed (AFMD) Germany $0.238B 0.00
HOOKIPA Pharma (HOOK) United States $0.237B 0.00
Pfenex (PFNX) United States $0.235B 0.00
XOMA (XOMA) United States $0.234B 0.00
Exicure (XCUR) United States $0.233B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
Pluristem Therapeutics (PSTI) Israel $0.207B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
IVERIC Bio (ISEE) United States $0.198B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
IBio (IBIO) United States $0.189B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Five Prime Therapeutics (FPRX) United States $0.184B 0.00
Aptinyx (APTX) United States $0.179B 0.00
Cerecor (CERC) United States $0.174B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.168B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.158B 0.00
TELA Bio (TELA) United States $0.156B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Celyad SA (CYAD) Belgium $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Arbutus Biopharma (ABUS) Canada $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.146B 0.00
Trevena (TRVN) United States $0.141B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.139B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
VolitionRX (VNRX) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.120B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.120B 3.07
AIT Therapeutics (XAIR) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.106B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
SESEN BIO, INC (SESN) United States $0.088B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
Celsion (CLSN) United States $0.086B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Apricus Biosciences (SEEL) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
CollPlant Holdings (CLGN) Israel $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
Spherix (AIKI) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00